Monovalent group A, group C meningococcal vaccines, and a bivalent vaccine for both groups A and C were licensed
On Jan. 3, 1978, the U.S. Food and Drug Administration (FDA) licensed the Monovalent group A (Menomune-A by…
The first monovalent (group C) meningococcal polysaccharide vaccine (Merck) was licensed
On Apr. 2, 1974, the U.S. Food and Drug Administration (FDA) licensed the first monovalent (group C) meningococcal…
Hoffmann-La Roche Research Laboratories, Squibb Institute for Medical Research jointly received the Lasker Award award
In 1955, Edward Robitzek, Irving Selikoff, Walsh McDermott and Carl Muschenheim, The Hoffmann-La Roche Research Laboratories, Squibb Institute…
Margaret Pittman showed precipitin reaction around meningococcus colonies on immune serum was correlated with mouse potency assay
In 1938, Margaret Pittman showed that the precipitin reaction around meningococcus colonies on immune serum agar plates was…
Margaret Pittman, Sara E. Branham, and E. M. Sockrider showed type specificity of meningococcus by use of the Petrie’s precipitin test
In 1937, Margaret Pittman, Sara E. Branham, and E. M. Sockrider showed the type specificity of meningococcus by…
Sara Branham identified a new organism, Neisseria flavescens, as a rare cause of meningitis and septicemia in humans
In 1930, Sara E. Branham identified a new organism, Neisseria flavescens, as a rare cause of meningitis and…